Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Journal of Virology Année : 2019

Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor

Olivier Schwartz

Résumé

SERINC5 is the long-searched-for antiviral factor that is counteracted by the HIV-1 accessory gene product Nef. Here, we engineered, via CRISPR/Cas9 technology, T-cell lines that express endogenous SERINC5 alleles tagged with a knocked-in HA epitope. This genetic modification enabled us to study basic properties of endogenous SERINC5 and to verify proposed mechanisms of HIV-1 Nef-mediated counteraction of SERINC5. Using this unique resource, we identified the susceptibility of endogenous SERINC5 protein to posttranslational modulation by type I IFNs and suggest uncoupling of Nef-mediated functional antagonism from SERINC5 exclusion from virions.

Domaines

Virologie
Fichier principal
Vignette du fichier
JVI.01221-19.pdf (1.64 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

pasteur-03253574 , version 1 (08-06-2021)

Licence

Paternité

Identifiants

Citer

Vânia Passos, Thomas Zillinger, Nicoletta Casartelli, Amelie Wachs, Shuting Xu, et al.. Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor. Journal of Virology, 2019, 93 (24), pp.e01221-19. ⟨10.1128/JVI.01221-19⟩. ⟨pasteur-03253574⟩
44 Consultations
92 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More